172 related articles for article (PubMed ID: 33630788)
21. Artificial vitreous replacements.
Soman N; Banerjee R
Biomed Mater Eng; 2003; 13(1):59-74. PubMed ID: 12652023
[TBL] [Abstract][Full Text] [Related]
22. Translation of hyaluronic acid-based vitreous substitutes towards current regulations for medical devices.
Schulz A; Germann A; Heinz WR; Engelhard M; Menz H; Rickmann A; Meiser I; Wien S; Wagner S; Januschowski K; Szurman P
Acta Ophthalmol; 2023 Jun; 101(4):422-432. PubMed ID: 36457299
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment.
Schnichels S; Schneider N; Hohenadl C; Hurst J; Schatz A; Januschowski K; Spitzer MS
PLoS One; 2017; 12(3):e0172895. PubMed ID: 28248989
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory responses after vitrectomy with vitreous substitutes in a rabbit model.
Barth H; Crafoord S; Arnér K; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):769-783. PubMed ID: 30656473
[TBL] [Abstract][Full Text] [Related]
25. Injectable alginate-based in situ self-healable transparent hydrogel as a vitreous substitute with a tamponading function.
Choi G; An SH; Choi JW; Rho MS; Park WC; Jeong WJ; Cha HJ
Biomaterials; 2024 Mar; 305():122459. PubMed ID: 38199216
[TBL] [Abstract][Full Text] [Related]
26. Forward Light Scattering of First to Third Generation Vitreous Body Replacement Hydrogels after Surgical Application Compared to Conventional Silicone Oils and Vitreous Body.
Hammer M; Herth J; Muuss M; Schickhardt S; Scheuerle A; Khoramnia R; Łabuz G; Uhl P; Auffarth GU
Gels; 2023 Oct; 9(10):. PubMed ID: 37888410
[TBL] [Abstract][Full Text] [Related]
27. Macro- and Microscale Properties of the Vitreous Humor to Inform Substitute Design and Intravitreal Biotransport.
Tram NK; Maxwell CJ; Swindle-Reilly KE
Curr Eye Res; 2021 Apr; 46(4):429-444. PubMed ID: 33040616
[TBL] [Abstract][Full Text] [Related]
28. A Hydrogel Vitreous Substitute that Releases Antioxidant.
Tram NK; Jiang P; Torres-Flores TC; Jacobs KM; Chandler HL; Swindle-Reilly KE
Macromol Biosci; 2020 Feb; 20(2):e1900305. PubMed ID: 31846211
[TBL] [Abstract][Full Text] [Related]
29. Vitreous substitutes: the present and the future.
Donati S; Caprani SM; Airaghi G; Vinciguerra R; Bartalena L; Testa F; Mariotti C; Porta G; Simonelli F; Azzolini C
Biomed Res Int; 2014; 2014():351804. PubMed ID: 24877085
[TBL] [Abstract][Full Text] [Related]
30. Vitreous Substitutes from Bench to the Operating Room in a Translational Approach: Review and Future Endeavors in Vitreoretinal Surgery.
Confalonieri F; Josifovska N; Boix-Lemonche G; Stene-Johansen I; Bragadottir R; Lumi X; Petrovski G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834754
[TBL] [Abstract][Full Text] [Related]
31. A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve.
Gao Q; Mou S; Ge J; To CH; Hui Y; Liu A; Wang Z; Long C; Tan J
Eye (Lond); 2008 Mar; 22(3):461-8. PubMed ID: 17525767
[TBL] [Abstract][Full Text] [Related]
32. A self-healing and injectable hydrogel based on water-soluble chitosan and hyaluronic acid for vitreous substitute.
Wang S; Chi J; Jiang Z; Hu H; Yang C; Liu W; Han B
Carbohydr Polym; 2021 Mar; 256():117519. PubMed ID: 33483040
[TBL] [Abstract][Full Text] [Related]
33. VITREORETINAL SURGERY WITH SILICONE OIL TAMPONADE IN PRIMARY UNCOMPLICATED RHEGMATOGENOUS RETINAL DETACHMENT: Clinical Outcomes and Complications.
Antoun J; Azar G; Jabbour E; Kourie HR; Slim E; Schakal A; Jalkh A
Retina; 2016 Oct; 36(10):1906-12. PubMed ID: 26966864
[TBL] [Abstract][Full Text] [Related]
34. Advances in Polysaccharide- and Synthetic Polymer-Based Vitreous Substitutes.
Naik K; Du Toit LC; Ally N; Choonara YE
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839888
[TBL] [Abstract][Full Text] [Related]
35. Biocompatibility of polyvinyl alcohol/trisodium trimetaphosphate as vitreous substitute in experimental vitrectomy model in rabbits.
de Oliveira RA; Muralha FP; Grupenmacher AT; de Araújo Morandim-Giannetti A; Bersanetti PA; Maia M; Magalhães Junior O
J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):460-466. PubMed ID: 34328263
[TBL] [Abstract][Full Text] [Related]
36. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes.
Wang P; Gao Q; Jiang Z; Lin J; Liu Y; Chen J; Zhou L; Li H; Yang Q; Wang T
Clin Exp Ophthalmol; 2012; 40(1):e67-75. PubMed ID: 21883770
[TBL] [Abstract][Full Text] [Related]
37. The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute.
Schramm C; Spitzer MS; Henke-Fahle S; Steinmetz G; Januschowski K; Heiduschka P; Geis-Gerstorfer J; Biedermann T; Bartz-Schmidt KU; Szurman P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):613-21. PubMed ID: 22199245
[TBL] [Abstract][Full Text] [Related]
38. [Early emulsification of silicone oil (2000 cs) in minimally invasive transconjunctival vitreoretinal surgery].
Maier MM; Engelmann V; Pfrommer S; Perz C; Lohmann C
Klin Monbl Augenheilkd; 2011 May; 228(5):477-9. PubMed ID: 20737357
[TBL] [Abstract][Full Text] [Related]
39. [Vitreous Substitute in Retinal Detachment Surgery - Why We Need a New Tamponade Strategy].
Szurman P
Klin Monbl Augenheilkd; 2017 Sep; 234(9):1094-1102. PubMed ID: 28895627
[TBL] [Abstract][Full Text] [Related]
40. Current Situation and Challenges in Vitreous Substitutes.
Mondelo-García C; Bandín-Vilar E; García-Quintanilla L; Castro-Balado A; Del Amo EM; Gil-Martínez M; Blanco-Teijeiro MJ; González-Barcia M; Zarra-Ferro I; Fernández-Ferreiro A; Otero-Espinar FJ
Macromol Biosci; 2021 Aug; 21(8):e2100066. PubMed ID: 33987966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
